You are here
Post-market responsibilities (biologicals)
Australian Regulatory Guidelines for Biologicals (ARGB)
If you supply biologicals in Australia then you need to know your responsibilities. This page will help you understand your responsibilities after your product is included on the Register.
Maintaining your ARTG entries
Being the sponsor of an entry in the ARTG, you need to:
- Continue to satisfy the conditions that were part of the approval for inclusion on the ARTG
- provide information to us about your product, if requested
- notify us of notifiable changes
- request a variation, when applicable
You may also want to:
Paying your fees & charges
When you have a biological included on the ARTG, you will need to pay an annual charge.
Applications for notification and variation have a fee or fees attached. Sometimes there is both an application and an evaluation fee.
Following approval of your manufacturing sites, there are a number of ongoing activities that you are responsible for, including maintaining the GMP conditions and accreditation and notifying TGA of any changes to the site or any overseas regulatory action for that site:
Biovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse events or any other problem related to biologicals.
Biovigilance responsibilities include:
To meet legislated requirements, you need a biovigilance system, which is used to fulfil the tasks and responsibilities associated with the detection, assessment, understanding and prevention of adverse effects of biologicals.
Some additional responsibilities for higher risk biologicals:
- A Risk Management Plan (RMP) is required for Class 3 and 4 biologicals.
- A Periodic Safety Update Report (PSUR) is required for Class 3 and 4 biologicals and when imposed for a particular Class 2 biological.
As a sponsor of a therapeutic good, you have ongoing responsibilities to ensure you are prepared for a recall and able to respond appropriately to complaints and problem reports:
Biologicals are not allowed to be advertised to the public:
|Version||Description of change||Author||Effective date|
|V1.0||Original publication incorporating new legislative changes and information previously published on the TGA website.||
Biological Science Section
Regulatory Guidance Team